Bilirubin, Total, Neonatal
Use
Evaluation for liver and biliary disease
Special Instructions
Not provided.
Limitations
The test is specifically designed and validated for use in newborn infants. Bilirubin levels may be affected by a variety of factors, such as prematurity, feeding practices, and genetic differences in bilirubin metabolism. Hemolysis or lipemia in specimens might lead to inaccurate results. The test should be used as part of a comprehensive clinical evaluation and interpretation should consider the entire clinical context, including concurrent medical conditions and potential laboratory artefacts.
Methodology
Automated Analyzer
Biomarkers
Bilirubin, Total
Analyte
LOINC Codes
- 1975-2 - Bilirub SerPl-mCnc
- 1975-2 - Bilirub SerPl-mCnc
Result Turnaround Time
1 day
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
0.2 mL
Minimum Volume
Not provided
Container
Red-top tube, gel-barrier tube, or green-top (lithium heparin) tube
Collection Instructions
If a red-top tube or plasma is used, transfer separated serum or plasma to a plastic transport tube. Protect from light.
Storage Instructions
Refrigerate.
Causes for Rejection
Use of oxalate, EDTA, or citrate plasma.
Other tests from different labs that may be relevant